David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Intellia Therapeutics
NTLA
$1.76B
| $230K | ﹤0.01% |
32,396
-1,187
| -4% | -$12K |
|
3752
Vital Farms
VITL
$476M
| $230K | ﹤0.01% |
7,541
-22,146
| -75% | -$797K |
|
3753
Corsair Gaming
CRSR
$1.18B
| $230K | ﹤0.01% |
25,933
-283,655
| -92% | -$2.8M |
|
3754
Invesco Water Resources ETF
PHO
$2.06B
| $229K | ﹤0.01% |
3,554
-400
| -10% | -$26.6K |
|
3755
Arcos Dorados Holdings
ARCO
$1.7B
| $228K | ﹤0.01% |
28,303
+6,050
| +27% | +$47.6K |
|
3756
Worthington Enterprises
WOR
$2.78B
| $228K | ﹤0.01% |
+4,545
| New | +$192K |
|
3757
VanEck Vietnam ETF
VNM
$517M
| $228K | ﹤0.01% |
18,263
-4,605
| -20% | -$54.6K |
|
3758
Global X FinTech ETF
FINX
$177M
| $226K | ﹤0.01% |
8,190
| – | – |
|
3759
Wynn Resorts
WYNN
$10.2B
| $225K | ﹤0.01% |
2,700
-41,597
| -94% | -$3.55M |
|
|
UHT
3760
Universal Health Realty Income Trust
UHT
$582M
| $225K | ﹤0.01% |
5,490
-6,225
| -53% | -$244K |
|
3761
Colony Bankcorp
CBAN
$454M
| $225K | ﹤0.01% |
13,907
-12,620
| -48% | -$207K |
|
3762
ALPS O'Shares US Small-Cap Quality Dividend ETF
OUSM
$867M
| $224K | ﹤0.01% |
+5,319
| New | +$231K |
|
3763
Twist Bioscience
TWST
$8.83B
| $223K | ﹤0.01% |
5,689
-101,579
| -95% | -$4.58M |
|
3764
MaxCyte
MXCT
$143M
| $223K | ﹤0.01% |
81,764
-26,837
| -25% | -$106K |
|
3765
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$764M
| $223K | ﹤0.01% |
5,484
| – | – |
|
3766
PUT
Analog Devices
ADI
$181B
| $222K | ﹤0.01% |
1,100
-88,200
| -99% | -$19.1M |
|
3767
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$828M
| $222K | ﹤0.01% |
7,455
-1,300
| -15% | -$39.4K |
|
3768
Prothena Corp
PRTA
$482M
| $220K | ﹤0.01% |
+17,803
| New | +$252K |
|
3769
CALL
Coeur Mining
CDE
$21.5B
| $220K | ﹤0.01% |
+37,200
| New | +$230K |
|
3770
CALL
Braze
BRZE
$3.54B
| $220K | ﹤0.01% |
+6,100
| New | +$245K |
|
|
BTX
3771
BlackRock Technology and Private Equity Term Trust
BTX
$1.03B
| $220K | ﹤0.01% |
35,139
| – | – |
|
3772
VictoryShares Free Cash Flow ETF
VFLO
$10.6B
| $220K | ﹤0.01% |
6,412
-19,596
| -75% | -$688K |
|
|
MAG
3773
DELISTED
MAG Silver
MAG
| $220K | ﹤0.01% |
14,392
+2,908
| +25% | +$45.1K |
|
3774
KT
KT
$9.03B
| $219K | ﹤0.01% |
+12,355
| New | +$213K |
|
3775
CALL
Aehr Test Systems
AEHR
$3.15B
| $219K | ﹤0.01% |
30,000
-32,900
| -52% | -$364K |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.